Sigachi Management Insights: Key Takeaways From The March 2025 Meeting; Should You Keep The Stock On Radar?

The largest manufacturer of microcrystalline cellulose (MCC) excipient in India and one of the top five worldwide is Sigachi Industries Ltd. (SIGACHI). Five of its manufacturing sites are in Hyderabad, and its main products are PIM coatings, FNN coatings, and pharma excipients and API intermediates. Over the past five years, the company's MCC business has expanded at a CAGR of over 21%. However, the company's announcement at Sigachi's March 2025 Management Meet that the management is confident in generating sales at a ~25% CAGR for the next several years is what makes the stock worth keeping an eye on.

SIGACHI has one of the highest MCC grades in the world, with almost 60 distinct grades. It's also because the company produces customized solutions in large quantities over an extended period of time. As a result, client loyalty grows. The majority of SIGACHI's clients have yearly volume contracts with set rates.

Over the past five years, the company's MCC revenue (83% of sales) has increased at a CAGR of around 21%, and its MCC production capacity has increased to about 21,700 MTPA, making it the largest MCC maker in India, up from about 14,000 MTPA previously.

According to a Share India Securities study, the company's O&M division has risen at a rate of over 31.0% CAGR during the previous five years. The brokerage has stated that "Sigachi Industries (SIGACHI) is India's largest manufacturer of microcrystalline cellulose (MCC) excipient and among the top 5 globally, for the same. MCC is one of the basic excipients in the pharma industry as it can be used as a main binder in a solid oral dosage or liquid form of a drug. We believe the company's global presence, technological expertise, and strong customer retention give it an edge in the excipients market and strong earnings prospects driven by recent capacity additions in MCC as well as foray in the API segment. We suggest to keep the stock on one's radar."

A Memorandum of Understanding (MoU) was recently signed on March 13th by Sigachi Industries and the Indian Navy (INS Kalinga) to work together to foster a culture of health and wellbeing through the "Vizag Navy Marathon Promo cum Conditioning Programme." From March 2025 to October 2025, the event will be held in Visakhapatnam on the second Sunday of each month.

Meanwhile, the company informed stock exchanges on Wednesday that "This is to inform that pursuant to the Company's Code of Conduct for Prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will remain closed for "Designated Persons" from Tuesday, April 1, 2025 till Forty Eight (48) hours after the dissemination of the Audited Financial Results (Consolidated and Standalone) of the Company for the quarter and year ended March 31, 2025. The Board Meeting will be scheduled, inter-alia, to consider and approve the audited Financial Results for the quarter and year ended March 31, 2025. Accordingly, an intimation regarding the notice of Board Meeting shall be sent separately to the Stock Exchanges."

With a market value of Rs 1,184.07 Cr, the small-cap pharmaceutical company's stock was trading at Rs 35.51 a share on Thursday on the BSE.